Compile Data Set for Download or QSAR
maximum 50k data
Found 24 Enz. Inhib. hit(s) with all data for entry = 5870
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM98020(US8486966, 17)
Affinity DataIC50:  3nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM98026(US8486966, 23)
Affinity DataIC50:  3nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM98010(US8486966, 2)
Affinity DataIC50:  3nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM50392789(CHEMBL2151319 | US8486966, 3)
Affinity DataIC50:  3nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM50392791(CHEMBL2151321 | US8486966, 1)
Affinity DataIC50:  3nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM50392793(CHEMBL2151323 | US8486966, 12)
Affinity DataIC50:  3nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM50392793(CHEMBL2151323 | US8486966, 12)
Affinity DataIC50:  3nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM98016(US8486966, 10)
Affinity DataIC50:  3nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM98015(US8486966, 9)
Affinity DataIC50:  3nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM98014(US8486966, 8)
Affinity DataIC50:  3nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM50392792(CHEMBL2151322 | US8486966, 7)
Affinity DataIC50:  3nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM98013(US8486966, 6)
Affinity DataIC50:  3nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM98018(US8486966, 14)
Affinity DataIC50:  4nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM98012(US8486966, 5)
Affinity DataIC50:  5nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM98017(US8486966, 13)
Affinity DataIC50:  6nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM98011(US8486966, 4)
Affinity DataIC50:  12nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM98020(US8486966, 17)
Affinity DataIC50:  14nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM50392790(CHEMBL2151320 | US8486966, 16)
Affinity DataIC50:  61nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM98024(US8486966, 21)
Affinity DataIC50:  96nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM98021(US8486966, 18)
Affinity DataIC50:  311nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM98023(US8486966, 20)
Affinity DataIC50:  475nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM98025(US8486966, 22)
Affinity DataIC50:  773nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM98019(US8486966, 15)
Affinity DataIC50:  3.81E+3nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM98022(US8486966, 19)
Affinity DataIC50:  7.25E+3nMT: 2°CAssay Description:JAK2 and Trk A kinase activity was determined by measuring the kinase's ability to phoshorylate synthetic tyrosine residues within a generic poly...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent